Historically, JPM week has been marked by at least a handful of high-dollar, high-profile acquisition events. This year we ...

At the Informa Biotech Showcase during JP Morgan Week in San Francisco, editor-in-chief Jonah Comstock caught up with ...

The first data has emerged on the uptake of Novo Nordisk's new oral version of GLP-1 agonist weight-loss therapy Wegovy, with ...

Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...

Ocugen also reported updated results from a phase 1 trial, which showed that ellipsoid zone (EZ) loss – which results in the ...

The study analysed more than 3,300 clinical notes produced during regular healthcare visits, from 200 anonymised patients, ...

What the deals have in common is price reductions for Medicaid, MFN prices for new launches, and discounts for self-paying ...

The era of experimentation is giving way to one of enterprise integration, where scale, safety, and alignment with regulation ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel, ...

AstraZeneca is mourning the loss of one of its top scientists after eminent cancer researcher José Baselga passed away at the age of just 61. Baselga was a heavyweight in oncology research, pursuing a ...

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. Francisco Partners is ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...